How biomarker panels actually work: what a blood test is doing

A blood draw is a tiny snapshot of biochemistry. Here is what the lab is doing with that vial — and what the numbers really mean.

TL;DR

A biomarker is anything measurable in the body that gives information about health — proteins, hormones, lipids, metabolites.
Labs measure them either with antibodies that grab the target (immunoassay) or with instruments that weigh the molecule directly (mass spectrometry).
Reference ranges differ between labs because each one calibrates against its own platform and population.

What it is

A biomarker panel is a group of measurements drawn from a single sample, usually blood. Routine panels include lipids (like LDL and HDL), liver enzymes, kidney markers, blood sugar, and a basic blood count. Specialized panels add hormones (testosterone, cortisol, IGF-1), inflammation markers (hs-CRP), advanced lipids (ApoB, Lp(a)), or metabolic markers. Each measurement is a snapshot of one molecule’s concentration at one moment in time.

How it works

Think of the lab as a quality-control station with two main tools. Tool one is an antibody — a Y-shaped protein engineered to grab one specific target molecule. Mix the antibody with the blood sample, and it sticks to whatever it was designed to find. A signal — color, light, fluorescence — then tells the instrument how much was there. This is an immunoassay (in plain English: a method that uses antibodies to detect and measure a target). Tool two is mass spectrometry (in plain English: an instrument that weighs molecules and identifies them by their mass-to-charge ratio). Mass spec is more specific and harder to fool but slower and more expensive (NIH PMC review, 2015).

Who asks about it

Patients new to detailed lab work often ask why their result was different at two different labs, or why a flagged value was actually fine on a recheck. Clinicians get the same question regularly. The answer almost always traces back to the assay platform, the reference range, or the day-to-day biological variability of the target itself. Understanding the mechanism makes the report less mysterious.

What the research says

A measurable result is the product of three things: the patient’s actual concentration, the assay’s accuracy, and the assay’s precision. Same-sample comparisons between labs show that for some hormones — testosterone is a classic example — different platforms can disagree by 20% or more, which is why endocrine societies recommend mass spec for borderline values (Rosner et al., 2007). Reference ranges are built from a “healthy” population in each lab’s geography; about 1 in 20 healthy people fall outside the range by definition.

What to know before considering it

A single result is a moment, not a verdict. The most actionable lab work is repeated over time — a trend means more than any single value. Pre-draw conditions matter: fasting status, time of day, recent exercise, hydration, and medications all shift specific markers. The most useful posture is to know which test was used (immunoassay vs mass spec), how to interpret a flagged value, and when a recheck is warranted before any plan changes.

The Halftime POV

Lab work is the closest thing to a measurable status report on biology. We use biomarkers to anchor decisions — but we treat any single result with the humility it deserves. Trends, context, and consistent methodology matter more than chasing a number on one day. Plain explanation, real signal.

Related reading:

FAQ

Q: What is a biomarker? A: A biomarker is anything measurable in the body that gives information about health, disease, or treatment response. Most of the ones on a routine panel are proteins, hormones, lipids, or metabolites in blood.

Q: Why do reference ranges vary between labs? A: Each lab calibrates its instruments and validates its reference range against its own local population. Different assay platforms can produce slightly different numbers for the same sample.

Q: What is the difference between an immunoassay and mass spectrometry? A: Immunoassays use antibodies that bind a specific target molecule, then measure the binding signal. Mass spectrometry weighs the molecule directly. Mass spec is generally more specific; immunoassays are faster and cheaper.

Disclaimer

This article is educational and is not medical advice. Compounded medications are not FDA-approved. Clinical outcomes depend on individual factors and require physician evaluation. Results vary. Halftime Health is launching soon — join the waitlist to get updates.

Get updates

Halftime Health is launching soon. We’ll share what we learn along the way — the research, the regulations, the real-world trade-offs. Join the waitlist and we’ll email you when we’re live.